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SUMMARY
Both insufficient and excessive maternal iodine 
consumption can result in congenital hypothyroidism. In 
East Asian cultures, seaweed is traditionally consumed 
in high quantities by peripartum women as it is thought 
to improve lactation. We present a case of transient 
congenital hypothyroidism due to maternal seaweed 
consumption at a daily basis during pregnancy and 
lactation in a Dutch family without Asian background. 
This case highlights that even in families of non- 
Asian background, high maternal intake of iodine- rich 
seaweed occurs and can result in transient or permanent 
hyperthyrotropinemia in the neonate with risk of 
impaired neurodevelopmental outcome if untreated.
BACKGROUND
Congenital hypothyroidism (CH) is a condition in 
which neonates have thyroid hormone deficiency. 
CH can be transient or permanent, depending on 
the aetiology and duration of hypothyroidism. 
Thyroidal causes such as agenesis or underdevel-
opment of the thyroidal gland (thyroid dysgen-
esis) or insufficient hormone synthesis (thyroid 
dyshormonogenesis) are the most common causes. 
Central CH due to absent or insufficient thyroid- 
stimulating hormone (TSH) secretion in the pitu-
itary gland is less common. Other causes are TSH 
receptor insensitivity and transient CH. Without 
early detection and treatment, neurodevelopment 
and metabolism are severely hampered. We present 
a case with CH due to an unusual cause in non- 
Asian infants, illustrating the importance of a thor-
ough patient history.
CASE PRESENTATION
We present a Dutch Caucasian boy who was referred 
at day 8 of life for abnormal CH screening with a 
T4 of 72 nmol/L blood (~144 nmol/L serum) with 
a SD of −0.9 on average in the batch of measure-
ments made that day (reference, >−1.6 SD) and a 
TSH of 23 mE/L (reference, <7 mE/L). Pregnancy 
and delivery were uneventful; he was born at 38 
weeks and 5 days of gestation with a body weight 
of 3350 g. The family history revealed no thyroidal 
problems, and he has a healthy brother. The boy is 
a peaceful baby and drinks breast milk ad libitum. 
His body weight decreased until day 6 and started 
to increase thereafter. Temperature and defecation 
were unremarkable. Hearing screening was initially 
insufficient, but normal at a repeat measurement. 
Except for mild jaundice that did not require photo-
therapy, physical examination revealed no abnor-
malities: especially, his pulse rate was normal and 
thyroidal enlargement was not palpable. Laboratory 
results showed repeatedly increased TSH concen-
trations, with free T4 (FT4) in the normal range, 
also described as hyperthyrotropinemia (figure 1). 
Our differential diagnosis was mild dyshormogen-
esis, partial TSH receptor insensitivity or transient 
causes of CH. At day 15, we performed a 123I- per-
chlorate discharge test, which displayed normal 123I 
uptake; however, after perchlorate administration, 
the uptake increased instead of decreased, suggesting 
a highly stimulated thyroid gland despite FT4 in the 
high- normal range. Ultrasound of the thyroidal gland 
performed at day 51 showed a normally sized and 
located thyroid gland without focal abnormalities.
At this point, history was repeated, which 
revealed that the mother consumed seaweed at a 
daily basis throughout pregnancy and lactation. She 
consumed a bowl of wakame miso soup daily, hijiki 
or arame seaweed once a week and nori seaweed 
once a week. In addition, she used chlorella (algae 
powder) and ‘sweet iron’ supplements during preg-
nancy. Her motivation for daily seaweed consump-
tion was the perceived health aspect.
Due to the lack of adequate reference ranges for 
mother’s milk and the lack of upper levels in urine 
that can cause hyperthyrotropinemia in the fetus and 
infant, we decided not to measure iodine concen-
tration in mother’s milk or urine. To exclude other 
causes of CH, we performed mutation analysis of 
the THRB gene and a gene panel for thyroidal CH, 
including the sequencing and copy number variance 
analysis of the following genes: CDCA8, DUOX1, 
DUOX2, DUOXA2, FOXE1, GLIS3, GNAS, 
HOXA3, IYD, JAG1, NKX2-1, PAX8, SLC26A4, 
SLC5A5, TG, TPO, TPST2 and TSHR. In these 
genes, no mutations or variations were found.
OUTCOME AND FOLLOW-UP
Cessation of maternal seaweed consumption was 
strongly advised. After cessation, TSH concentra-
tions gradually decreased but did not normalise. 
The FT4 concentrations remained in the normal 
range. As a result of TSH values being >10 mU/L, 
the mother was strongly recommended to supple-
ment her infant with levothyroxine to prevent long- 
term complications. However, so far the mother 
was reluctant to start supplementation because 
of normal FT4 concentrations. During follow- up 
until 9 months of age, his neurodevelopment was 
normal. We will continue to follow up the thyroid 
function and development of this boy.
DISCUSSION
This case illustrates the importance of a detailed 
history including maternal iodine exposure, even in 
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populations without cultural or ethnic background known for 
high seaweed consumption.
In our case, the excess maternal iodine during pregnancy and 
lactation due to daily seaweed consumption resulted in congen-
ital transient hypothyroidism.
Direct iodine overload to the neonate can be caused by iodine- 
containing disinfection agents or contrast medium administra-
tion during the perinatal period or can be caused by iodine- rich 
medication or diet. Maternal exposure to iodine can result in high 
iodine concentrations in the fetus and newborn due to placental 
transfer and/or by secretion of iodine in breast milk.1 2 The 
thyroid possesses protective mechanisms for excess iodine: the 
so- called Wolff- Chaikoff effect. In cases of excess iodine, iodine 
uptake in the thyroid gland is blocked by a decreased activity of 
the iodine symporter, leading to reduced T4 and increased TSH 
concentrations. In adults, this blockage lasts on average for 48 
hours.3 The fetus and neonate are very sensitive to excess iodine 
because the Wolff- Chaikoff effect is not functional until gesta-
tional week 36. The fetus membranes are highly permeable, and 
the fetus can absorb iodine from the amniotic fluid through the 
skin or gastrointestinal tract, or iodine is transferred through the 
placenta. In addition, iodine trapping processes in the thyroid 
gland are active, and iodine renal clearance is low.4 The dura-
tion of the blockage of iodine transport into the thyroid gland in 
neonates can last for weeks to months.4
In many East Asian cultures, seaweed soup is considered 
a healthy staple. Korean mothers are traditionally given large 
amounts of brown seaweed soup postpartum, up to 4–5 times a 
day in the first few days after delivery, to promote breast milk 
supply. The iodine content of seaweed products is highly variable. 
Especially seaweed types such as kelp, kombu and Sargassum 
have very high iodine contents and can contain >1000 µg of 
iodine per gram product.5 6 Harvesting, storage and cooking 
methods can greatly affect iodine content. It was reported that 
250 mL of seaweed soup can provide 500–1700 µg of iodine, 
based on whether the seaweed itself is consumed or not.7
The Dutch recommended daily allowance (RDA) for iodine is 
based on Scandinavian RDAs (2012).8 For pregnant women, the 
RDA is considered to be 175 µg/day and during lactation to be 
200 µg/day. No RDA for infants <6 months was established. An 
RDA for infants between 80 µg and 110 µg has been proposed 
by others.9 10 The European Food Safety Authority established 
the tolerable upper limit that is considered safe for adults to be 
600 µg/day, and the maximal amount for infants aged <1 year is 
not established.11 The WHO proposed an upper limit for chil-
dren aged <2 years to be 180 µg/day.12 Daily ingestion of iodine- 
rich seaweed products easily exceeds the daily recommended 
intake of iodine as in our case. In addition to iodine, seaweed 
contains several minerals, vitamins, soluble fibres and flavonoids 
which are considered to have beneficial effects on lifestyle- 
related diseases, but also contains heavy metals such as arsenic, 
which can have detrimental health effects.13
Published cases of CH due to excess maternal dietary iodine 
are limited to families with Asian background. In a Korean study, 
subclinical hypothyroidism in preterm infants was associated 
with high iodine concentrations in breast milk. These Korean 
postpartum women traditionally consumed brown seaweed 
soups, resulting in excess iodine in a third of infants.14 In a study 
in Japan in 34 neonates with abnormal CH screening, 44% 
were diagnosed with hyperthyrotropinemia, that is, high TSH, 
caused by excess maternal ingestion of iodine during pregnancy, 
of which 80% required levothyroxine because of hypothyrox-
inemia or persistent hyperthyrotropinemia. In addition, it was 
suggested that hyperthyrotropinemia due to excessive maternal 
iodide ingestion during pregnancy may be permanent.4 Possible 
risk factors for permanent hyperthyrotropinemia in these 
infants may be repeated excess iodine due to placental transfer, 
breast milk and baby food. In these infants, thyroid function 
may be permanently altered, possibly by an intrauterine iodine 
imprinting effect.4
In Australia, New Zealand, UK and USA, four cases of iodine- 
induced neonatal hypothyroidism due to maternal seaweed 
consumption are reported. In all of these four cases, the mothers 
had an Asian background.15–17 All these infants needed treatment 
with levothyroxine for a duration of 4 months to 2 years.
Whether or not to treat children with (permanent) hyperthy-
rotropinemia and normal FT4 concentrations is still a contro-
versial subject. Levothyroxine therapy might be considered with 
Figure 1 Trend in FT4 and TSH from birth onwards, illustrating the effect of maternal seaweed consumption on TSH concentration. FT4, free T4; TSH, 
thyroid- stimulating hormone.
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persistent TSH concentrations above 10 U/L, mainly because of 
the potential long- term increased risk of cardiovascular morbidity 
and mortality. This is mainly investigated in Hashimoto- related 
hyperthyrotropinemia or other autoimmune diseases.18 In 
mothers with Graves’ disease, neonatal hyperthyrotropinemia is 
often transient.19 After maternal iodine consumption, neonatal 
thyroid function may be permanently altered, possibly by an 
intrauterine iodine imprinting effect, resulting in persistent 
hyperthyrotropinemia (with or without low FT4 concentrations) 
with potential negative effects on cardiovascular health.
Since TSH was spontaneously decreasing in our case, we 
decided not to supplement with levothyroxine yet.
This case illustrates the importance of a detailed history 
including maternal iodine exposure even in populations without 
cultural/ethnic background known for high seaweed consump-
tion. Maternal seaweed consumption can result in transient or 
permanent hyperthyrotropinemia in the neonate with risk of 
neurodevelopmental outcome if untreated.
Learning points
 ► Maternal diet should be included in the history of all 
neonates referred for screening of abnormal congenital 
hypothyroidism.
 ► Even in families of non- Asian background, high maternal 
intake of iodine- rich seaweed occurs and can result in 
transient or permanent hyperthyrotropinemia in the neonate 
with risk of neurodevelopmental outcome if untreated.
 ► Food safety institutes, general healthcare providers, 
gynaecologists and midwives should advise pregnant and 
lactating women not to ingest iodine- rich foods on a daily 
basis because seaweed iodine content is highly variable and 
easily exceeds recommended daily allowances.
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